- Home
- CLMT vs ZLAB Comparison
CLMT vs ZLAB Comparison
Compare CLMT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLMT | ZLAB |
|---|---|---|
| Founded | 1916 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CLMT | ZLAB |
|---|---|---|
| Price | $34.16 | $21.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $28.65 | ★ $49.60 |
| AVG Volume (30 Days) | ★ 845.7K | 587.3K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.39 | 38.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,137,100,000.00 | $460,156,000.00 |
| Revenue This Year | $3.94 | $9.75 |
| Revenue Next Year | $1.07 | $26.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $11.00 | $15.96 |
| 52 Week High | $36.94 | $44.34 |
Technical Indicators
Market Signals| Indicator | CLMT | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 61.11 | 49.02 |
| Support Level | $17.70 | $16.88 |
| Resistance Level | $36.94 | $25.28 |
| Average True Range (ATR) | 1.15 | 0.86 |
| MACD | 0.01 | -0.32 |
| Stochastic Oscillator | 93.32 | 14.83 |
Price Performance
Historical ComparisonAbout CLMT Calumet Specialty Products Partners L.P.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.